Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC18624 Roslin-2

    Benzylhexamethylenetetramine bromide

    A reactivator of p53
  3. GC18611 Fusicoccin

    壳梭孢(菌)素,Fusicoccin A

    A phytotoxin
  4. GC18604 Calcein Blue AM

    Calcein Blue Acetoxymethyl ester

    A fluorogenic dye
  5. GC18566 AZD 3147 A dual mTORC1/mTORC2 inhibitor
  6. GC18556 Degarelix (acetate)

    地加瑞克杂质

    A synthetic GNRHR antagonist
  7. GC18547 Psoromic Acid

    茶痂衣酸

    An inhibitor of Rab geranylgeranyl transferase and P. falciparum FAS II enzymes
  8. GC18536 Chartreusin

    教酒菌素

    An antibiotic with diverse biological activites
  9. GC18530 CAY10616

    顺式3,4',5-三甲氧基-3'-羟基二苯乙烯

    Pro-apoptotic analog of resveratrol
  10. GC18522 Phosphatidylserines (sodium salt)

    L-α-磷脂酰丝氨酸(钠盐),L-α-Phosphatidylserine

    A mixture of phosphatidylserines isolated from soy
  11. GC18518 Apcin An inhibitor of the APC/C
  12. GC18516 (+)-Aeroplysinin-1

    (+)-Aeroplysinin-1

    A sea sponge metabolite with diverse biological activities
  13. GC18476 Biotin-VAD-FMK A biotin-conjugated pan-caspase inhibitor
  14. GC18458 Terrein

    土曲霉酮

    A fungal metabolite with diverse biological activities
  15. GC18449 Cardanol monoene

    腰果酚(C15:1),Cardanol C15

    An inhibitor of tyrosinase with anticancer properties
  16. GC18439 Doxorubicinone

    阿霉酮,Adriamycin aglycone; Adriamycinone

    A metabolite of doxorubicin
  17. GC18437 Alternariol monomethyl ether

    交链孢霉甲基醚

    A mycotoxin
  18. GC18421 Dabcyl-YVADAPV-EDANS

    Dabcyl-ICE-EDANS

    A fluorogenic substrate for caspase-1
  19. GC18404 Lometrexol

    洛美曲索,DDATHF

    A GART inhibitor
  20. GC18392 Cellocidin

    乙炔二羰酰胺

    An antibiotic
  21. GC18363 Mca-DEVDAPK(Dnp)-OH

    Caspase-3 Fluorogenic Substrate III, CPP32 Fluorogenic Substrate III, 7-Methoxycoumarin-4-acetyl-DEVDAPK(Dnp)-OH, Mca-Asp-Glu-Val-Asp-Ala-Pro-Lys(Dnp)-OH

    A caspase-3 fluorogenic substrate
  22. GC18315 Calpain Inhibitor VI

    SJA6017

    A calpain and cathepsin inhibitor
  23. GC18308 UNC569 A TAM family kinase inhibitor
  24. GC18241 Lysophosphatidylcholines

    L-溶血卵磷脂,Lyso-Lecithins (egg)

    A glycerophospholipid
  25. GC18226 Ac-LEHD-AMC (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate

    A caspase-9 fluorogenic substrate
  26. GC18206 WT161 A potent inhibitor of HDAC6
  27. GC18177 WEHI-345

    N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺

    An inhibitor of RIPK2
  28. GC18173 TM5441 A PAI-1 inhibitor
  29. GC12861 Z-VAD-FMK

    氟甲基酮,Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone,Z-Val-Ala-Asp(OMe)-FMK

    Z-VAD-FMK(苄氧羰基-Val-Ala-Asp(OMe)氟甲基酮),是一种类似ICE的蛋白酶抑制剂,通过阻止CPP32转化为其活性形式来抑制细胞凋亡。
  30. GC11302 Hinokitiol

    桧木醇; β-Thujaplicin

    A tropolone with diverse biological activities
  31. GC10520 Dextran sulfate sodium salt (M.W 200000)

    硫酸葡聚糖钠盐

    A sulfated polysaccharide

  32. GC15168 Urolithin A

    尿石素A

    A metabolite of ellagic acid with diverse biological activities

  33. GC13400 Ac-VDVAD-AFC

    N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)

    A fluorogenic substrate for caspase-2
  34. GC13859 Z-DEVD-AFC

    Caspase-3 Fluorogenic Substrate IV

    A caspase-3 fluorogenic substrate
  35. GC12367 CM-272 An inhibitor of G9a, GLP, and DNA methyltransferases
  36. GC16037 7BIO

    7-Bromoindirubin-3’-oxime

    A caspase-independent (nonapoptotic) cell death inducer
  37. GC15267 Se-Aspirin

    Selenium-acetylsalicylic Acid

    A selenium-NSAID hybrid
  38. GC14791 F16 A potential antitumor agent
  39. GC13058 NK 252 A Nrf2 activator
  40. GC13034 ML-291 An activator of apoptosis through UPR
  41. GC10628 nor-NOHA (acetate)

    Nω-hydroxy-nor-Arginine

    nor-NOHA(醋酸盐)(α-氨基酸 N(omega) -Hydroxy-Nor-L-arginine)是一种有效且可逆的选择性精氨酸酶抑制剂,nor-NOHA(醋酸盐)的效力大约是 40 倍NOHA 抑制未受刺激的小鼠巨噬细胞催化 l-精氨酸水解为 l-鸟氨酸(nor-NOHA IC(50) 值 12 77777#177;5µM。
  42. GC12223 Z-Asp-CH2-DCB

    Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone

    A pan-caspase inhibitor
  43. GC14847 Psoralidin

    补骨脂定

    A furanocoumarin with anti-cancer activity
  44. GC17632 Maslinic Acid

    山楂酸; Crategolic acid; 2α-Hydroxyoleanolic acid

    Maslinic Acid是一种五环三萜酸,广泛存在于橄榄和其他植物中。Maslinic Acid具有抗炎、抗氧化、抗肿瘤、降血糖和神经保护等多种生物活性。
  45. GC15457 Pyridoxine

    吡哆醇; Pyridoxol

    A 4-methanol form of vitamin B6
  46. GC10951 Ac-DEVD-CMK

    Ac-Asp-Glu-Val-Asp-CMK,Caspase-3 Inhibitor III

    An inhibitor of caspase-3
  47. GC17602 Ac-DEVD-AFC

    AC-ASP-GLU-VAL-ASP-7-氨基-4-三氟甲基香豆素,N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-Trifluoromethylcoumarin,Caspase-3 Substrate (Fluorogenic)

    A fluorogenic caspase subsrate
  48. GC11716 SIRT1/2 Inhibitor IV

    Cambinol,NSC 112546,SIRT1 Inhibitor II,SIRT2 Inhibitor VI

    Cell-permeable inhibitor of SIRT1 and SIRT2
  49. GC11217 CUR 61414

    G-856

    A potent inhibitor of hedgehog-induced activity
  50. GC15613 p-nitro-Cyclic Pifithrin-α

    Cyclic pifithrin-α-p-nitro,p-nitro-Cyclic PFT-α

    A cell-permeable form of cyclic PFT-α
  51. GC15258 GN25 Inhibits p53-Snail binding

Items 1901 to 1950 of 2733 total

per page

Set Descending Direction